4//SEC Filing
ONYX PHARMACEUTICALS INC 4
Accession 0001209191-08-012060
CIK 0001012140operating
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 3:37 PM ET
Size
6.8 KB
Accession
0001209191-08-012060
Insider Transaction Report
Form 4
KENNEY EDWARD F
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2008-02-19$36.67/sh−24$880→ 28,158 total - Sale
Common Stock
2008-02-19$35.67/sh−226$8,061→ 28,182 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Includes an aggregate of 1,408 shares purchased in 2007 through the Issuer's ESPP.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012140
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 3:37 PM ET
- Size
- 6.8 KB